AccuMeter theophylline test

AccuMeter theophylline test

A term for a disposable, single-use, point-of-care assay to measure theophylline levels in whole blood.
References in periodicals archive ?
ChemTrak's AccuMeter Theophylline Test enables the physician to monitor theophylline drug levels with ease -- during a single office visit.
The Company believes that its AccuMeter Theophylline Test will be, if approved by Japanese authorities, the only non-instrumented, quantitative, whole-blood test for theophylline offered in Japan.
pylori Test, used to detect the presence of antibodies to the bacterium associated with ulcers; and the ChemTrak AccuMeter Theophylline Test, recently cleared by the FDA, to monitor the concentration of the asthma drug Theophylline in blood.
Pylori Test to determine the presence of a bacterium associated with duodenal and peptic ulcers and the AccuMeter Theophylline Test, a point-of-care quantitative assay for theophylline, a drug commonly used for the treatment of asthma, have been cleared for marketing to physicians' office labs by the Food and Drug Administration.
Pylori Test to determine the presence of bacterium associated with duodenal and peptic ulcers and the ChemTrak AccuMeter Theophylline Test, a point-of-care quantitative assay for theophylline, a drug commonly used for the treatment of asthma.
Pylori Test to determine the presence of bacterium associated with duodenal and peptic ulcers and the AccuMeter Theophylline Test, a point-of-care quantitative assay for theophylline, a drug commonly used for the treatment of asthma, have been cleared for marketing to physicians' office labs by the Food and Drug Administration.
Pylori Test to determine the presence of bacterium associated with duodenal and peptic ulcers, and the AccuMeter Theophylline Test, a point-of-care quantitative assay for theophylline, a drug commonly used for the treatment of asthma, have been cleared for marketing to physicians' office labs by the Food and Drug Administration.
Pylori Test determines the presence of bacterium associated with duodenal and peptic ulcers and the ChemTrak Accumeter Theophylline Test, a point-of-care quantitative assay for theophylline, a drug prescribed for asthmatics, was recently cleared for marketing by the FDA.
NASDAQ:CMTR) announced it has received FDA clearance to market a new point-of-care quantitative assay for theophylline, the Accumeter Theophylline Test.
The ChemTrak Accumeter Theophylline Test is a single use, disposable, self contained, noninstrumented technology capable of the quantitative measurement of the drug in whole blood with 99% accuracy.
pylori test and for the company's quantitative immunoassay AccuMeter Theophylline test for respiratory applications.